What’s new

• Tushar Mandal appointed CFO effective 2 July 2026.
• He replaces Parth Palera, who resigned on 25 June to pursue another opportunity.
• Mandal has been with Deccan Healthcare for over 8 years handling finance.

Why it matters

For a nano-cap pharma firm with a ₹33 crore market cap, an internal CFO appointment signals stability after an unexpected departure. But with no terms disclosed and the prior CFO leaving abruptly, the board still needs to demonstrate longer-term governance depth.

What we’re watching

• Any further C-suite changes at the company.
• Whether the company discloses Mandal's compensation package.
• If the resignation is linked to any broader governance issues.

The full read

Deccan Healthcare filled the CFO vacancy quickly. Parth Palera resigned on 25 June; the board appointed Tushar Mandal, an 8‑year company veteran, effective 2 July 2026. No surprise there — an internal hire for a known opening. For a ₹33 crore pharma firm, the move provides governance stability after an unexpected exit, but the lack of disclosed terms means the market learns nothing new. The open question is whether more C‑suite changes follow.

Primary source: BSE · NSE